BioCentury | Oct 21, 2020
Deals

With roots in Medivation, Nuvation finds quick route to listing via year’s largest SPAC deal

...OrbiMed Advisors and Wellington Management, in addition to existing investors the Baupost Group, Tavistock Group’s Boxer Capital...
BioCentury | Oct 13, 2020
Finance

Oct. 13 Quick Takes: Sovereign wealth fund backs Evotec; plus Canaan, EdiGene, Cedilla, Rappta and Lassogen

...Inc. closed a $57.6 million series B round co-led by Casdin Capital and Tavistock Group’s Boxer Capital...
BioCentury | Sep 24, 2020
Finance

Sept. 23 Quick Takes: Zai raises $776M, Silverback $85M; plus Novartis, PureTech, UCB and more

...raised an $85 million series C round led by EcoR1 Capital, with participation by new investors Boxer Capital...
BioCentury | Sep 4, 2020
Product Development

Rain to advance growing precision oncology pipeline with $63M series B

...Daiichi Sankyo —through clinical proof of concept.  Boxer Capital...
...– RAD52 homolog Danielle Golovin milademetan (DS-3032) Tarlox, tarloxotinib Rain Therapeutics Inc. Boxer Capital Cormorant...
BioCentury | Aug 26, 2020
Deals

Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues

...led the Chinese biotech’s $115 million series C round.  Additional new investors Lilly Asia Ventures, Boxer Capital...
BioCentury | Aug 4, 2020
Finance

Interest in protein degradation runs hot as Kymera files for IPO

...BCTG Acquisition Corp., a blank-check company that is seeking to merge with a private biotech. Boxer Capital...
BioCentury | Aug 3, 2020
Finance

After raising crossover-heavy $70M round, p53 play PMV likely one of the next preclinical IPOs

...joining OrbiMed is continuing to back the company are Nextech Invest, Viking Global Investors and Boxer Capital...
BioCentury | Jul 23, 2020
Product Development

Encoded to drive first gene therapy into clinic with GV-led $135M series D

...drew participation from existing investors Matrix Capital Management, Arch Venture Partners, Illumina Ventures, RTW Investments, Boxer Capital...
BioCentury | Jul 17, 2020
Finance

July 16 Quick Takes: Biotech stocks fare worse than others in STAR tumble; plus BioAtla, Exalys, Virometix, Biose, Spirea

...Cormorant Asset Management, Farallon Capital Management LLC, Pappas Capital LLC, funds managed by Janus Henderson, Boxer Capital...
BioCentury | Jun 26, 2020
Finance

Poseida brings in $110M ahead of IPO as more biotechs line up for NASDAQ debuts

...when it raised $125 million in a series B2 round led by RA Capital and Boxer Capital...
Items per page:
1 - 10 of 70
BioCentury | Oct 21, 2020
Deals

With roots in Medivation, Nuvation finds quick route to listing via year’s largest SPAC deal

...OrbiMed Advisors and Wellington Management, in addition to existing investors the Baupost Group, Tavistock Group’s Boxer Capital...
BioCentury | Oct 13, 2020
Finance

Oct. 13 Quick Takes: Sovereign wealth fund backs Evotec; plus Canaan, EdiGene, Cedilla, Rappta and Lassogen

...Inc. closed a $57.6 million series B round co-led by Casdin Capital and Tavistock Group’s Boxer Capital...
BioCentury | Sep 24, 2020
Finance

Sept. 23 Quick Takes: Zai raises $776M, Silverback $85M; plus Novartis, PureTech, UCB and more

...raised an $85 million series C round led by EcoR1 Capital, with participation by new investors Boxer Capital...
BioCentury | Sep 4, 2020
Product Development

Rain to advance growing precision oncology pipeline with $63M series B

...Daiichi Sankyo —through clinical proof of concept.  Boxer Capital...
...– RAD52 homolog Danielle Golovin milademetan (DS-3032) Tarlox, tarloxotinib Rain Therapeutics Inc. Boxer Capital Cormorant...
BioCentury | Aug 26, 2020
Deals

Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues

...led the Chinese biotech’s $115 million series C round.  Additional new investors Lilly Asia Ventures, Boxer Capital...
BioCentury | Aug 4, 2020
Finance

Interest in protein degradation runs hot as Kymera files for IPO

...BCTG Acquisition Corp., a blank-check company that is seeking to merge with a private biotech. Boxer Capital...
BioCentury | Aug 3, 2020
Finance

After raising crossover-heavy $70M round, p53 play PMV likely one of the next preclinical IPOs

...joining OrbiMed is continuing to back the company are Nextech Invest, Viking Global Investors and Boxer Capital...
BioCentury | Jul 23, 2020
Product Development

Encoded to drive first gene therapy into clinic with GV-led $135M series D

...drew participation from existing investors Matrix Capital Management, Arch Venture Partners, Illumina Ventures, RTW Investments, Boxer Capital...
BioCentury | Jul 17, 2020
Finance

July 16 Quick Takes: Biotech stocks fare worse than others in STAR tumble; plus BioAtla, Exalys, Virometix, Biose, Spirea

...Cormorant Asset Management, Farallon Capital Management LLC, Pappas Capital LLC, funds managed by Janus Henderson, Boxer Capital...
BioCentury | Jun 26, 2020
Finance

Poseida brings in $110M ahead of IPO as more biotechs line up for NASDAQ debuts

...when it raised $125 million in a series B2 round led by RA Capital and Boxer Capital...
Items per page:
1 - 10 of 70